Urologix, Inc.
ULGXOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$2182
P/E Ratio—
52W High$0.0126
52W Low$0.0001
Urologix, Inc. (ULGX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ULGX · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2015Report Date: May 12, 2015EPS Actual
-$0.02
Revenue
$0.00B
Fiscal Period
Q2 FY2015
FY ends December
Report Date
May 12, 2015
After Market Close
✓ 1-Quarter EPS Beat Streak
ULGX reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2015 | May 12, 2015 | — | -$0.02 | — | $0.00B | — | — |
| — Q1 FY2015 | Feb 5, 2015 | — | -$0.02 | — | $0.00B | — | — |
| — Q4 FY2014 | Nov 4, 2014 | — | -$0.02 | — | $0.00B | — | — |
| — Q3 FY2014 | Aug 19, 2014 | — | -$0.17 | — | $0.00B | — | — |
| — Q2 FY2014 | May 6, 2014 | — | -$0.08 | — | $0.00B | — | — |
| — Q1 FY2014 | Feb 4, 2014 | — | -$0.05 | — | $0.00B | — | — |
| — Q4 FY2013 | Oct 29, 2013 | — | -$0.06 | — | $0.00B | — | — |
| — Q3 FY2013 | Aug 20, 2013 | — | -$0.05 | — | $0.00B | — | — |
Q2 FY2015
May 12, 2015
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2015
Feb 5, 2015
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2014
Nov 4, 2014
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2014
Aug 19, 2014
EPS Actual
-$0.17
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2014
May 6, 2014
EPS Actual
-$0.08
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2014
Feb 4, 2014
EPS Actual
-$0.05
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2013
Oct 29, 2013
EPS Actual
-$0.06
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2013
Aug 20, 2013
EPS Actual
-$0.05
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
No analyst estimates available for ULGX.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2015 | May 12, 2015 | — | $0.11 | $0.11 | +0.00% |
| — Q1 FY2015 | Feb 5, 2015 | — | $0.09 | $0.07 | -17.65% |
| — Q4 FY2014 | Nov 4, 2014 | — | $0.11 | $0.11 | +0.00% |
| — Q3 FY2014 | Aug 19, 2014 | — | $0.13 | $0.13 | +0.00% |
| — Q2 FY2014 | May 6, 2014 | — | $0.16 | $0.19 | +18.75% |
| — Q1 FY2014 | Feb 4, 2014 | — | $0.15 | $0.17 | +9.93% |
| — Q4 FY2013 | Oct 29, 2013 | — | $0.23 | $0.22 | -4.35% |
| — Q3 FY2013 | Aug 20, 2013 | — | $0.34 | $0.38 | +11.71% |
Q2 FY2015+0.00%
Report Date
May 12, 2015
EPS Beat/Miss
—
Price Before
$0.11
Price After
$0.11
Q1 FY2015-17.65%
Report Date
Feb 5, 2015
EPS Beat/Miss
—
Price Before
$0.09
Price After
$0.07
Q4 FY2014+0.00%
Report Date
Nov 4, 2014
EPS Beat/Miss
—
Price Before
$0.11
Price After
$0.11
Q3 FY2014+0.00%
Report Date
Aug 19, 2014
EPS Beat/Miss
—
Price Before
$0.13
Price After
$0.13
Q2 FY2014+18.75%
Report Date
May 6, 2014
EPS Beat/Miss
—
Price Before
$0.16
Price After
$0.19
Q1 FY2014+9.93%
Report Date
Feb 4, 2014
EPS Beat/Miss
—
Price Before
$0.15
Price After
$0.17
Q4 FY2013-4.35%
Report Date
Oct 29, 2013
EPS Beat/Miss
—
Price Before
$0.23
Price After
$0.22
Q3 FY2013+11.71%
Report Date
Aug 20, 2013
EPS Beat/Miss
—
Price Before
$0.34
Price After
$0.38
Beat Rate0 / 8 quarters
Largest Move+18.75% (Q2 FY2014)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ULGX ends December
Urologix, Inc. (ULGX) most recently reported earnings on May 12, 2015 for Q2 FY2015, posting EPS of $-0.02 (in line with the analyst consensus of —). The next ULGX earnings date is expected around September 1, 2026.
Each quarter, investors track ULGX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ULGX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ULGX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ULGX earnings · 4 questionsUrologix, Inc.'s next earnings report is expected around September 1, 2026. ULGX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ULGX historically reports after market close (AMC).
ULGX earnings datewhen is ULGX earningsULGX next earnings datewhen does ULGX report earningsULGX earnings calendar
▸ Source: FMP · Urologix, Inc. SEC filings · US GAAP · Urologix, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026